Document:

Form of Class J Warrant issued to Ki Nam

 Exhibit 4.8 
 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT,
THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 SERIES J COMMON STOCK PURCHASE WARRANT 
 T3 MOTION, INC. 
  

			
	 Warrant Shares: 50,000
	  	Date: June 28, 2011

 THIS SERIES J COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value
received, Ki Yong Nam and Yeong Hee Nam, Trustees of the Nam Family Trust DTD 2/17/97. (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or
after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on April 25, 2016 (the “Termination Date”) but not thereafter, to subscribe for and purchase from T3 Motion, Inc., a
Delaware corporation (the “Company”), up to 50,000 shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined
in Section 2(b). 
 Section 1. Exercise. 

a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in
part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the
address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto accompanied by payment of the aggregate Exercise Price of the Warrant Shares thereby purchased by wire
transfer or cashier’s check drawn on a United States bank. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation 

 
within three business days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase
of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof. 

b) Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $3.50, subject to
adjustment hereunder (the “Exercise Price”). 
 c) Cashless Exercise. If at any time
after the 18-month anniversary of the date of the Purchase Agreement, there is no effective Registration Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may also be
exercised at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where: 

 

					
	(A)	 	=	  	the VWAP on the Business Day immediately preceding the date of the delivery of the Notice of Exercise;
			
	(B)	 	=	  	the Exercise Price of this Warrant, as adjusted; and
			
	(X)	 	=	  	the number of Warrant Shares issuable upon exercise of this Warrant in accordance with the terms of this Warrant by means of a cash exercise rather than a cashless
exercise.

 d) Mechanics of Exercise. 

i. Delivery of Certificates Upon Exercise. Certificates for shares purchased hereunder shall be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder’s prime broker with the Depository Trust Company through its Deposit Withdrawal Agent Commission (“DWAC”) system if the Company is then a participant in such
system and either (A) there is an effective Registration Statement permitting the resale of the Warrant Shares by the Holder or (B) the shares are eligible for resale without volume or manner-of-sale limitations pursuant to Rule 144, and
otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise within seven business days from the delivery to the Company of the Notice of Exercise Form, surrender of this Warrant (if required) and payment of the
aggregate Exercise Price as set forth above (the “Warrant Share Delivery Date”). This Warrant shall be deemed to have been exercised on the date the Exercise Price is received by the Company. The Warrant Shares shall be deemed to
have been issued, and Holder or any other 

  
 2 

 
person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised by payment to the Company
of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 1(e)(vi) prior to the issuance of such shares, have been paid. 

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall,
at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to Holder a new Warrant evidencing the rights of Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant. 
 iii. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which Holder would
otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next
whole share. 
 iv. Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made
without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of
the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.

 v. Closing of Books. The Company will not close its stockholder books or records in any manner which
prevents the timely exercise of this Warrant, pursuant to the terms hereof. 
 Section 2. Adjustments 

a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a
stock dividend or otherwise make a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of
Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common
Stock into a smaller number of shares or (iv) issues by reclassification of shares 

  
 3 

 
of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of
Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of shares issuable upon
exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 2(a) shall become effective immediately after the record date
for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. 

b) Calculations. All calculations under this Section 2 shall be made to the nearest cent or the nearest
1/100th of a share, as the case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury
shares, if any) issued and outstanding. 
 c) Notice to Holder. Whenever the Exercise Price is adjusted
pursuant to any provision of this Section 2, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. 

Section 3. Transfer of Warrant. 
 a) Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 3(d) hereof, this Warrant and all rights hereunder (including, without
limitation, any registration rights unless inclusion of such transferee would require filing a post-effective amendment) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. The
assignee shall also agree to all terms of the Transaction Documents as applicable. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as
applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The
Warrant, if properly assigned, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. 
 b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and
denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 3(a), as to any transfer which may be involved in such division or combination, the

  
 4 

 
Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto. 
 c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record
Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary. 
 d) Transfer Restrictions. If, at the time of the surrender of this Warrant in
connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or
(ii) eligible for resale without volume or manner-of-sale restrictions pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, Holder’s compliance with the restrictive legend set forth on the front page of
this Warrant. 
 Section 4. Miscellaneous. 

a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights or other
rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 1(e)(i). 
 b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of
such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate. 

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration
of any right required or granted herein is a day on which banking institutions in the State of New York are authorized by law to close, then such action may be taken or such right may be exercised on the next succeeding day which shall not be such a
day. 
 d) Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of
the State of California. 

  
 5 

 e) Restrictions. The Holder acknowledges that the Warrant Shares
acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws. 
 f) Notices. All notices and other communications from the Company to the Holder shall be mailed by first class registered or certified mail, postage prepaid, at such address as may have been
furnished to the Company in writing by such Holder or, until any such Holder furnishes to the Company an address, then to, and at the address of, the last Holder who has so furnished an address to the Company. 

g) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations
evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of all Holders from time to time
of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares. 
 h) Headings. The
headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant. 
 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated. 

 

			
	T3 MOTION, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 6 

 NOTICE OF EXERCISE 
 To:    T3 MOTION, INC. 
 (1) The undersigned hereby elects to
purchase             Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any. 
 (2) Payment shall take the form of (check applicable box): 

 ̈ in lawful money of the United States; or 

 ̈ [if permitted] the cancellation of such number of Warrant Shares as is necessary, in
accordance with the formula set forth in subsection 1(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 1(c). 

(3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as
is specified below: 
  

					
	  	  	  
	  	 

 The Warrant Shares shall be delivered to the following DWAC Account Number or by
physical delivery of a certificate to: 
  

					
	  	  	  
	  	 
	 	  	  
	  	 
	 	  	  
	  	 

 (4) Accredited Investor. The undersigned is an “accredited
investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended. 
 [SIGNATURE OF HOLDER] 

 

	
	 Name of Investing Entity:
                                         
                                         
                                         
                         

	 Signature of Authorized Signatory of Investing Entity:
                                         
                                         
                     

	 Name of Authorized Signatory:
                                         
                                         
                                         
                

	 Title of Authorized Signatory:
                                         
                                         
                                         
                  

	 Date:
                                         
                                         
                                         
                                         
                 

  
 7 

 ASSIGNMENT FORM 

(To assign the foregoing warrant, execute 
 this form and supply required information. 
 Do not use this form to exercise the
warrant.) 
 FOR VALUE RECEIVED, [        ] all of or
[            ] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to 
  

					
	                           
                                         
                                         
                                         
                           whose address is	 	 
	                             
                                         
                                         
                                         
                                         
               .	 		 	
	  
	 		 	

  

									
		  		  	 Dated:
                    ,         
	  	
		  	Holder’s Signature:	  	  
	  	
		  	Holder’s Address:	  	  
	  	
		  	  
	  	
	Signature Guaranteed:	  	  
	  	

 NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant,
without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to
assign the foregoing Warrant. 

  
 8Form of Director Indemnification Agreement

 Exhibit 10.8 
 T3 MOTION, INC. 
 INDEMNIFICATION AGREEMENT 

THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of
[            ], by and between T3 Motion, Inc., a Delaware corporation (the “Company”), and
[            ] (“Covered Agent”). 

RECITALS 

WHEREAS, Covered Agent performs a valuable service to the Company in his capacity as a director and/or officer of the Company;

 WHEREAS, the Company’s Bylaws, as amended and/or restated (the “Bylaws”), provide for the
indemnification of the directors, officers, employees and other agents of the Company, including persons serving at the request of the Company in such capacities with other corporations or enterprises, as authorized by the Delaware General
Corporation Law (the “DGCL”); 
 WHEREAS, the Bylaws and the DGCL, by their non-exclusive nature,
permit contracts between the Company and its agents, officers, employees and other agents with respect to indemnification of such persons; and 
 WHEREAS, in order to induce Covered Agent to continue to serve as a director and/or officer of the Company, the Company has determined and agreed to enter into this Agreement with Covered Agent.

 NOW, THEREFORE, in consideration of Covered Agent’s continued service as a director and/or officer of the Company
after the date hereof, the parties hereto agree as follows: 
 AGREEMENT 

1. Services to the Company. Covered Agent will serve, at the will of the Company or under separate contract, if any such contract exists, as a
director and/or officer of the Company or as a director, officer or other fiduciary, employee or agent of an affiliate of the Company, including any subsidiary or employee benefit plan of the Company (each, an “Affiliate”);
provided, however, that Covered Agent may at any time and for any reason resign from such position(s) (subject to any contractual obligation that Covered Agent may have assumed apart from this Agreement or any obligation imposed by operation
of law) and that neither the Company nor any Affiliate shall have an obligation under this Agreement to continue Covered Agent in any such position(s). This Agreement shall not be deemed an employment contract between the Company (or any of its
subsidiaries) and Covered Agent. This foregoing notwithstanding, this Agreement shall continue in force after Covered Agent has ceased to serve as a director and/or officer of the Company or as a director, officer, employee or agent of the Company
or any Affiliate. 

 2. Indemnity of Covered Agent. The Company hereby agrees to hold harmless and
indemnify Covered Agent to the fullest extent authorized or permitted by the provisions of the Bylaws and the DGCL, as the same may be amended from time to time (but only to the extent that such amendment permits the Company to provide broader
indemnification rights than the Bylaws or the DGCL permitted prior to adoption of such amendment). 
 3. Additional
Indemnity. In addition to and not in limitation of the indemnification otherwise provided for herein, and subject only to the exclusions set forth in Section 4 hereof, the Company hereby further agrees to hold harmless and indemnify
Covered Agent: 
 (a) Against any and all Expenses (as defined below) that Covered Agent becomes legally obligated to pay
because of any claim or claims made against or by Covered Agent in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, arbitrational, administrative or investigative, and whether formal or
informal (including an action by or in the right of the Company), to which Covered Agent is, was or at any time becomes a party or a participant, including as a witness or otherwise, or is threatened to be made a party or participant, by reason of
the fact that Covered Agent is, was or at any time becomes a director, officer, employee or other agent of the Company, or is or was serving or at any time serves at the request of the Company as a director, officer, employee or other agent of
another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, including a subsidiary of the Company (collectively, a “Proceeding”). The definition of Proceeding shall be considered met if
Covered Agent in good faith believes the situation might lead to the institution of a Proceeding. “Expenses” shall mean all expenses, including attorneys’ fees, witness fees, damages, judgments, fines and amounts paid in
settlement, any federal, state, local or foreign taxes imposed on Covered Agent as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties imposed on Covered Agent, costs associated with any
appeals, including without limitation the premium, security for, and other costs relating to any costs bond, supersedes bond, or other appeal bond or its equivalent, and any other amounts for time spent by Covered Agent for which Covered Agent is
not compensated by the Company or any Affiliate or third party (i) for any period during which Covered Agent is not an agent, in the employment of, or providing services for compensation to, the Company or any Affiliate, and (ii) if the
rate of compensation and the estimated time involved is approved by the members of the Company’s Board of Directors (the “Board”) who are not parties to any action with respect to which expenses are incurred, for Covered
Agent while an agent of, employed by, or providing services for compensation to the Company or any Affiliate. 
 (b) Otherwise
to the fullest extent as may be provided to Covered Agent by the Company under the non-exclusivity provisions of the DGCL and the Bylaws, as the same may be amended from time to time (but only to the extent that such amendment permits the Company to
provide broader indemnification rights than permitted prior to adoption of such amendment). 

  
 -2-

 4. Limitations on Additional Indemnity. No indemnity pursuant to
Section 2 or 3 hereof shall be paid by the Company: 
 (a) on account of any claim against Covered Agent
solely for an accounting of profits made from the purchase or sale by Covered Agent of securities of the Company pursuant to the provisions of Section 16(b) of the Exchange Act (as defined below) (“Section 16(b)”), or
similar provisions of any federal, state or local statutory law; provided that, with respect to a claim against Covered Agent solely for an accounting of profits made from the purchase or sale by Covered Agent of securities of the Company
pursuant to the provisions of Section 16(b), Covered Agent shall be entitled to the advancement of legal expenses unless the Company reasonably determines that Covered Agent clearly violated Section 16(b) and must disgorge profits to the
Company pursuant to the terms thereof. Notwithstanding anything to the contrary stated or implied in this Section 4(a), indemnification pursuant to this Agreement relating to any Proceeding against Covered Agent for an accounting of
profits made from the purchase or sale by Covered Agent of securities of the Company pursuant to the provisions of Section 16(b) or similar provisions of any federal, state or local laws shall not be prohibited if Covered Agent ultimately
establishes in any Proceeding that no recovery of such profits from Covered Agent is permitted under Section 16(b) or similar provisions of any federal, state or local laws; 

(b) for which payment is actually made to Covered Agent under a valid and collectible insurance policy or under a valid and enforceable
indemnity clause, bylaw or agreement, except in respect of any excess beyond payment under such insurance, clause, bylaw or agreement; 
 (c) if indemnification is not lawful under applicable law; or 
 (d) in connection
with any Proceeding (or part thereof) initiated by Covered Agent, or any Proceeding by Covered Agent against the Company or its directors, officers, employees or other agents, unless (i) such indemnification is expressly required to be made by
law, (ii) the Proceeding was authorized by the Board, (iii) such indemnification is provided by the Company, in its sole discretion, pursuant to the powers vested in the Company under the DGCL or any other applicable law, (iv) the
Proceeding is initiated pursuant to Section 9 hereof, or (v) the Proceeding initiated by Covered Agent is a cross-claim or counter-claim. 
 5. Continuation of Indemnity. All agreements and obligations of the Company contained herein shall continue during the period Covered Agent is a director, officer, employee or other agent of the
Company (or is or was serving at the request of the Company as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise) and shall continue thereafter so long
as Covered Agent shall be subject to any Proceeding by reason of the fact that Covered Agent was serving in the capacity referred to herein. 
 6. Partial Indemnification. Covered Agent shall be entitled under this Agreement to indemnification by the Company for a portion of the Expenses that Covered Agent becomes legally obligated to pay
in connection with any Proceeding referred to in Section 3 hereof even if not entitled hereunder to indemnification for the total amount thereof, and the Company shall indemnify Covered Agent for the portion thereof to which Covered
Agent is entitled. 
 7. Notification and Defense of Claim. Not later than 30 days after receipt by Covered Agent of
notice of the commencement of any Proceeding, Covered Agent will, if a 

  
 -3-

 
claim in respect thereof is to be made against the Company under this Agreement, notify the Company of the commencement thereof; but the omission so to notify the Company will not relieve the
Company from any liability which it may have to Covered Agent under this Agreement or otherwise than under this Agreement, except to the extent (solely with respect to the indemnity under this Agreement) that such omission to notify materially
prejudices the Company. With respect to any such Proceeding as to which Covered Agent notifies the Company of the commencement thereof: 
 (a) the Company will be entitled to participate therein at its own expense; 
 (b)
except as otherwise provided below, the Company may, at its option and jointly with any other indemnifying party similarly notified and electing to assume such defense, assume the defense thereof, with counsel reasonably satisfactory to Covered
Agent. After notice from the Company to Covered Agent of its election to assume the defense thereof, the Company will not be liable to Covered Agent under this Agreement for any expenses subsequently incurred by Covered Agent in connection with the
defense thereof except for reasonable costs of investigation or otherwise as provided below. Covered Agent shall have the right to employ separate counsel in such Proceeding, but the fees and expenses of such counsel incurred after notice from the
Company of its assumption of the defense thereof shall be at the expense of Covered Agent unless (i) the employment of counsel by Covered Agent has been authorized by the Company, (ii) Covered Agent has reasonably concluded, and so
notified the Company, that there is an actual conflict of interest between the Company and Covered Agent in the conduct of the defense of such action, (iii) the Company shall not in fact have employed counsel to assume the defense of such
action, in each of which cases the fees and expenses of Covered Agent’s separate counsel shall be at the expense of the Company, (iv) there has been a Change in Control, or (v) Covered Agent shall have reasonably concluded that
counsel engaged by the Company on behalf of Covered Agent may not adequately represent Covered Agent. A “Change in Control” shall mean: (a) the acquisition, directly or indirectly, by any person or group (within the
meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the beneficial ownership of securities of the Company possessing more than fifty percent (50%) of the combined
voting power of all outstanding securities of the Company; (b) a merger or consolidation in which the Company is not the surviving entity, except for a transaction in which the holders of the outstanding voting securities of the Company
immediately prior to such merger or consolidation hold, in the aggregate, securities possessing more than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the surviving entity immediately after such
merger or consolidation; (c) the sale, transfer or other disposition (in one or more transactions or series of related transactions) of all or substantially all of the assets of the Company; (d) a complete liquidation or dissolution of the
Company; or (e) any reverse merger in which the Company is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding voting securities are
transferred to or acquired by one or more persons or entities different from the persons or entities holding those securities immediately prior to such merger. If, under applicable laws and rules of attorney professional conduct, there exists a
potential, but not actual, conflict of interest between the Company and Covered Agent, the Company’s indemnification and Expense advancement obligations to Covered Agent under this Agreement shall include reasonable legal fees and reasonable
costs incurred by Covered Agent for separate counsel retained by Covered Agent to monitor the Proceeding (so that such separate 

  
 -4-

 
counsel may assume Covered Agent’s defense if the conflict of interest between the Company and Covered Agent becomes an actual conflict of interest). The existence of an actual or potential
conflict, and whether any such conflict may be waived, shall be determined pursuant to the rules of attorney professional conduct and applicable law. The Company shall not be entitled to assume the defense of any Proceeding brought by or on behalf
of the Company or as to which Covered Agent shall have made the conclusion provided for in clause (ii) above; and 
 (c)
the Company shall not be liable to indemnify Covered Agent under this Agreement for any amounts paid in settlement of any action or claim effected without its written consent, which shall not be unreasonably withheld. The Company shall be permitted
to settle any action except that it shall not settle any action or claim in any manner which would impose any penalty or limitation on Covered Agent without Covered Agent’s written consent, which may be given or withheld in Covered Agent’s
sole discretion. 
 8. Advances of Expenses. 
 (a) Covered Agent shall have the right to advancement by the Company prior to the final adjudication of any Proceeding of any and all Expenses relating to, arising out of or resulting from any Proceeding
paid or incurred by Covered Agent or which Covered Agent determines are reasonably likely to be paid or incurred by Covered Agent. The right to advances under this paragraph shall in all events continue until final disposition of any Proceeding,
including any appeal therein. Advances shall be made without regard to Covered Agent’s ability to repay the Expenses and without regard to Covered Agent’s ultimate entitlement to indemnification under the other provisions of this
Agreement. Advances shall be unsecured and interest free. Advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the
Company to support the advances claimed. 
 (b) Covered Agent’s right to such advancement is not subject to the
satisfaction of any standard of conduct. Without limiting the generality or effect of the foregoing, within five business days after any request by Covered Agent, the Company shall, in accordance with such request (but without duplication),
(i) pay such Expenses on behalf of Covered Agent, (ii) advance to Covered Agent funds in an amount sufficient to pay such Expenses, or (iii) reimburse Covered Agent for such Expenses. 

(c) Covered Agent shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an
undertaking providing that Covered Agent undertakes to the fullest extent permitted by law to repay the advance (without interest) if and to the extent that it is ultimately determined by a court of competent jurisdiction in a final judgment, not
subject to appeal, that Covered Agent is not entitled to be indemnified by the Company. No other form of undertaking shall be required other than the execution of this Agreement. The Company shall not initiate any proceeding seeking repayment of any
advanced Expenses pursuant to the foregoing undertaking other than (i) in connection with the underlying and operative proceeding for which Covered Agent has received such advanced expenses or (ii) by a proceeding initiated in the Court of
Chancery of the State of Delaware following a final judgment, not subject to appeal, by a court of competent jurisdiction of the underlying and operative proceeding for which Covered Agent received such advanced Expenses. 

  
 -5-

 9. Enforcement; Presumption of Entitlement. 

(a) Any right to indemnification or advances granted by this Agreement to Covered Agent shall be enforceable by or on behalf of Covered
Agent in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of such claim is made within 30 days of request therefor. Covered Agent, in such
enforcement action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting Covered Agent’s claim. 
 (b) It shall be a defense to any action for which a claim for indemnification is made under Section 3 hereof (other than an action brought to enforce a claim for Expenses pursuant to
Section 8 hereof) that Covered Agent is not entitled to indemnification because of the limitations set forth in Section 4 hereof. Neither the failure of the Company (including the Board or the Company’s stockholders) to
have made a determination prior to the commencement of such enforcement action that indemnification of Covered Agent is proper in the circumstances, nor an actual determination by the Company (including the Board or the Company’s stockholders)
that such indemnification is improper shall be a defense to the action or create a presumption that Covered Agent is not entitled to indemnification under this Agreement or otherwise. 

(c) In any such Proceeding instituted by Covered Agent pursuant to this Section 9, the Company shall be precluded from
asserting that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the Company is bound by all the provisions of this Agreement and is precluded from making any
assertion to the contrary. 
 (d) In making any determination concerning Covered Agent’s right to indemnification, there
shall be a presumption that Covered Agent has satisfied the applicable standard of conduct, and the Company may overcome such presumption only by its adducing clear and convincing evidence to the contrary. For purposes of any determination of good
faith, Covered Agent shall be presumed to have acted in good faith if Covered Agent’s action is based on the records or books of account of the Company, including financial statements, or on information supplied to Covered Agent by the officers
of the Company in the course of their duties, or on the advice of legal counsel for the Company or the Board or counsel selected by any committee of the Board or on information or records given or reports made to the Company by an independent
certified public accountant or by an appraiser, investment banker, compensation consultant, or other expert selected with reasonable care by the Company or the Board or any committee of the Board. The provisions of this Section 9(d)
shall not be deemed to be exclusive or to limit in any way the other circumstances in which Covered Agent may be deemed to have met the applicable standard of conduct. Whether or not the foregoing provisions of this Section 9 are satisfied, it
shall in any event be presumed that Covered Agent has at all times acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. Any determination concerning Covered Agent’s right to
indemnification that is adverse to Covered Agent may be challenged by Covered Agent in the Court of Chancery of the State of Delaware. No determination by the Company (including without limitation by its directors or any independent counsel) that
Covered Agent has not satisfied any applicable standard of conduct shall be a defense to any claim by Covered Agent for indemnification or reimbursement or advance payment of Expenses by the Company hereunder or create a presumption that Covered
Agent has not met any applicable standard of conduct. 

  
 -6-

 (e) The termination of any Proceeding by judgment, order, settlement (with or without court
approval), conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Covered Agent to indemnification or create a presumption that
Covered Agent did not act in good faith and in a manner which Covered Agent reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal proceeding, that Covered Agent had reasonable cause to
believe that Covered Agent’s conduct was unlawful. 
 (f) If the person or persons so empowered to make a determination
concerning Covered Agent’s right to indemnification pursuant to this Agreement shall have failed to make the requested determination within 30 days after any judgment, order, settlement, dismissal, arbitration award, conviction, acceptance of a
plea of nolo contendere or its equivalent, or other disposition or partial disposition of any Proceeding or any other event that could enable the Company to determine Covered Agent’s entitlement to indemnification, the requisite determination
that Covered Agent is entitled to indemnification shall be deemed to have been made. 
 (g) The remedies provided for in this
Section 9 shall be in addition to any other remedies available to Covered Agent at law or in equity. 
 10.
Subrogation. In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Covered Agent, who shall execute all documents required and shall do all acts that
may be necessary to secure such rights and to enable the Company effectively to bring suit to enforce such rights. 
 11.
Non-Exclusivity of Rights. The rights conferred on Covered Agent by this Agreement shall not be exclusive of any other right which Covered Agent may have or hereafter acquire under any statute, provision of the Company’s Certificate of
Incorporation, as amended and/or restated, or Bylaws, each as may be amended and/or restated from time to time, agreement, vote of stockholders or directors, or otherwise, both as to action in Covered Agent’s official capacity and as to action
in another capacity while holding office. 
 12. Survival of Rights; Change in Control. 

(a) The rights conferred on Covered Agent by this Agreement shall continue after Covered Agent has ceased to be a director, officer,
employee or other agent of the Company or to serve at the request of the Company as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise and shall inure to
the benefit of Covered Agent’s heirs, executors and administrators. 
 (b) The Company shall require and cause any
successor thereto (whether direct or indirect) in connection with a Change in Control, by written agreement, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to
perform if no such Change in Control occurred. 

  
 -7-

 13. Contribution. To the fullest extent permitted by applicable law, if the
indemnification provided for in this Agreement is unavailable to Covered Agent for any reason whatsoever, the Company, in lieu of indemnifying Covered Agent, shall contribute to the amount incurred by or on behalf of Covered Agent, whether for
judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in
light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Covered Agent as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the
relative fault of the Company (and its directors, officers, employees and agents) and Covered Agent in connection with such event(s) and/or transaction(s). 
 14. Liability Insurance. 
 (a) For the duration of Covered Agent’s
service as a director and/or officer of the Company, and thereafter for so long as Covered Agent shall be subject to any pending or possible indemnifiable claim, the Company shall use commercially reasonable efforts (taking into account the scope
and amount of coverage available relative to the cost thereof) to cause to be maintained in effect policies of directors’ and officers’ liability insurance providing coverage for directors and/or officers of the Company that is at least
substantially comparable in scope and amount to that provided by the Company’s current policies of directors’ and officers’ liability insurance. The minimum AM Best rating for the insurance carriers of such insurance shall be not less
than A-VI. 
 (b) In the event of a Change in Control, the Company shall (i) maintain in force any and all insurance
policies then maintained by the Company in providing directors’ and officers’ insurance, in respect of Covered Agent, or (ii) require and cause any successor thereto (whether direct or indirect) to obtain and maintain a
directors’ and officers’ liability insurance policy that provides coverage for Covered Agent that is at least substantially comparable in scope and amount to that provided to Covered Agent by the Company as of immediately prior to the
Change in Control, in each case for the six-year period immediately following the Change in Control. This “tail coverage” shall be placed by the Company’s insurance broker. 

(c) In the event that any action is instituted by Covered Agent under this Agreement or under any liability insurance policies maintained
by the Company to enforce or interpret any of the terms hereof or thereof, Covered Agent shall be entitled to be paid all Expenses incurred by Covered Agent with respect to such action, regardless of whether Covered Agent is ultimately successful in
such action, and shall be entitled to the advancement of Expenses with respect to such action, unless as a part of such action a court of competent jurisdiction over such action determines that each of the material assertions made by Covered Agent
as a basis for such action was not made in good faith or was frivolous. 
 (d) The Company shall make available to Covered Agent
with a copy of all directors’ and officers’ liability insurance applications, binders, policies, declarations, endorsements and other related materials. The Company shall not discontinue or significantly reduce the scope or amount of
coverage from one policy period to the next without the prior approval thereof by a majority vote of the incumbent directors of the Company, even if less than a quorum. 

  
 -8-

 15. Optional Trust. The Company may, but shall not be required to create a trust
fund, grant a security interest or use other means, including without limitation a letter of credit, to ensure the payment of such amounts as may be necessary to satisfy its obligations to indemnify and advance Expenses pursuant to this Agreement.

 16. No Imputation. The knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the
Company or the Company itself shall not be imputed to Covered Agent for purposes of determining any rights under this Agreement. 
 17. Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality and
enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal
or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary to conform to
applicable law and to give the maximum effect to the intent of the parties hereto; and (iii) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement
containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. 

18. Coverage; Superseding Prior Agreement. This Agreement shall apply with respect to Covered Agent’s service as a director,
officer, employee or other agent of the Company or any Affiliate prior to the date of this Agreement. This Agreement hereby amends, restates, supersedes and replaces any other prior Indemnification Agreements between Covered Agent and the Company
(the “Prior Agreement”) in its entirety. 
 19. Governing Law. This Agreement shall be
interpreted and enforced in accordance with the laws of the State of Delaware (without regard to conflicts of laws principles). 

20. Amendment; Termination and Waiver. No amendment, modification, waiver, termination or cancellation of this Agreement shall be
effective unless in writing signed by the Company and Covered Agent. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar) nor shall such waiver
constitute a continuing waiver. 
 21. Period of Limitations. No legal action shall be brought and no cause of action
shall be asserted by or in the right of the Company against Covered Agent, Covered Agent’s estate, spouse, heirs, administrators, executors or personal or legal representatives after the expiration of two years from the date of accrual of such
cause of action, and any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two-year period; provided, however, that if any shorter period of
limitations is otherwise applicable to any such cause of action, such shorter period shall govern. 

  
 -9-

 22. Specific Performance. The Company and Covered Agent agree that a monetary remedy
for breach of this Agreement may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Covered Agent irreparable harm. Accordingly, the parties hereto agree that Covered Agent may enforce this Agreement by
seeking injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Covered Agent shall not be precluded from seeking or
obtaining any other relief to which he may be entitled. The Company and Covered Agent further agree that Covered Agent shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary
injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Covered Agent by a court
of competent jurisdiction, and the Company hereby waives any such requirement of a bond or undertaking. 
 23. Offset Against
Other Rights. The Company’s obligation to indemnify, hold harmless or advance Expenses hereunder to Covered Agent who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary,
employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Covered Agent has actually received as indemnification, hold harmless or exoneration payments or
advancement of expenses from such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise. Notwithstanding any other provision of this Agreement to the contrary, (i) Covered Agent shall have no obligation
to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage among multiple parties possessing such duties to Covered Agent prior to the Company’s satisfaction
and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement without regard to whether Covered Agent holds, may pursue or has pursued any indemnification,
advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company. 
 24. Information Sharing. If the Covered Agent is the subject of or is implicated in any way during an investigation, whether formal or informal, to the extent not prohibited by any applicable law,
rule, regulation or order, the Company shall share with Covered Agent any information it has turned over to any third parties concerning the investigation (“Shared Information”). By executing this agreement, Covered Agent
agrees that such Shared Information is material non-public information that Covered Agent is obligated to hold in confidence and may not disclose publicly; provided, however, that Covered Agent is permitted to use the Shared Information and
to disclose such Shared information to Covered Agent’s legal counsel solely in connection with defending Covered Agent from legal liability. 
 25. Identical Counterparts; Facsimile Delivery. This Agreement may be executed in one or more counterparts, including counterparts transmitted by facsimile or other electronic communication, each
of which shall for all purposes be deemed to be an original but all of which together shall constitute but one and the same Agreement. Only one such counterpart need be produced to evidence the existence of this Agreement. Facsimile signatures, or
signatures delivered by other electronic transmission, shall be as effective as original signatures. 

  
 -10-

 26. Headings. The headings of the sections of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction hereof. 
 27.
Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given (i) upon delivery if delivered by hand to the party to whom such communication was directed,
(ii) when sent by confirmed electronic mail, with verification of receipt, or by facsimile, in either case, if sent during regular business hours; if not, then on the next business day; or (iii) upon the third business day after the date
on which such communication was mailed if mailed by certified or registered mail, return receipt requested, with postage prepaid. 
 (a) All communications shall be delivered to Covered Agent at the address indicated on the signature page hereof, or at such other address as Covered Agent shall designate by ten days’ advance
written notice to the Company. 
 (b) All communications shall be delivered to the Company at T3 Motion, Inc., 2990 Airway
Avenue, Suite A, Costa Mesa, California 92660, Attention: Chief Financial Officer, or such other address as may have been furnished to Covered Agent by the Company. 
 [Signature page follows] 

  
 -11-

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the
day and year first above written. 
  

			
	T3 MOTION, INC.
		
	By:	 	  

	Name:	 	
	Its:	 	
	
	COVERED AGENT
	
	  

	Signature
	
	  

	Print Name
		
	Address:	 	  

	
	  

	
	  

  
 [SIGNATURE
PAGE TO INDEMNIFICATION AGREEMENT]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]